Product
HSK31679
Aliases
HSK31679 160mg, HSK31679 80mg, HSK31679 high dose, HSK31679 low dose (1 other aliases)
3 clinical trials
4 indications
Indication
HealthyIndication
Elevated LDL-CIndication
Non-Alcoholic SteatohepatitisIndication
HypercholesterolemiaClinical trial
A Multicenter, Double-blind, Placebo Randomized , Phase2b Study to Evaluate the Efficacy and Safety of HSK31679 in Chinese Patients With Non-Alcoholic Steatohepatitis (NASH).Status: Recruiting, Estimated PCD: 2026-01-01
Clinical trial
A Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses and Multiple Dose of HSK31679 in Healthy Volunteers and Subjects With Elevated LDL-CStatus: Completed, Estimated PCD: 2022-09-21
Clinical trial
A Phase 2 ,Multicentre, Randomised, Double Blind Double Simulation, Placebo and Positive Controlled Study to Evaluate the Efficacy and Safety of HSK31679 in Patients With Hypercholesterolemia With Non-alcoholic Fatty Liver DiseaseStatus: Completed, Estimated PCD: 2024-02-20